Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade)
Source: SeekingAlpha
2026-03-06 12:04:03 ET
It has been eight months since I last took an in-depth look at a biopharma concern called Aurinia Pharmaceuticals Inc. ( AUPH ). I concluded that article by calling the stock "quite cheap" and noted that I had a covered call stake in the equity....
Read the full article on Seeking Alpha
For further details see:
Aurinia Pharmaceuticals: Waiting For Another Opportunity (Downgrade)
Aurinia Pharmaceuticals Inc
NASDAQ: AUPH
AUPH Trading
0.24% G/L:
$16.44 Last:
176,645 Volume:
$16.46 Open:
AUPH Latest News
June 04, 2026 07:00:00 am
LUPKYNIS Associated with a Statistically Significant 53% Reduction in Risk of Renal-Related Event or Death
June 03, 2026 12:43:00 am
TANG CAPITAL MANAGEMENT, LLC FILES EARLY WARNING REPORT RESPECTING AURINIA PHARMACEUTICALS INC.
May 19, 2026 08:30:00 am
Aurinia Pharmaceuticals Completes Successful Tender Offer for Kezar Life Sciences
AUPH Stock Data
$1,932,123,392
126,527,384
2.24%
102
N/A
Biotechnology & Life Sciences
Healthcare
CA
Edmonton
